Lixte Biotechnology Stock Forward View - Triple Exponential Smoothing

LIXT Stock  USD 2.74  -0.17  -5.84%   
This reference page presents Triple Exponential Smoothing forecast data for Lixte Biotechnology Holdings. The model output shown here is derived from Lixte Biotechnology's historical price series and is provided for informational purposes.
The Triple Exponential Smoothing forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 2.71 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.63.As with simple exponential smoothing, in triple exponential smoothing models past Lixte Biotechnology observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Lixte Biotechnology Holdings observations. This Triple Exponential Smoothing forecast data for Lixte Biotechnology Holdings is sourced from the most recent available trading data and is intended solely as reference information.
Triple exponential smoothing for Lixte Biotechnology - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Lixte Biotechnology prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Lixte Biotechnology price movement. However, neither of these exponential smoothing models address any seasonality of Lixte Biotechnology.

Triple Exponential Smoothing Price Forecast For the 22nd of March

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Lixte Biotechnology Holdings on the next trading day is expected to be 2.71 with a mean absolute deviation of 0.13 , mean absolute percentage error of 0.03 , and the sum of the absolute errors of 7.63 .
Please note that although there have been many attempts to predict Lixte Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lixte Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Stock Forecast Pattern

Backtest Lixte Biotechnology  Lixte Biotechnology Price Prediction  Research Analysis  

Forecasted Value

Forecasting Lixte Biotechnology Holdings for the next session involves measuring the model's historical ability to define credible downside and upside scenarios. At the moment, the model places downside around 0.03 and upside around 8.08 for the forecasting period.
Market Value
2.74
2.71
Expected Value
8.08
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Lixte Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Lixte Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0268
MADMean absolute deviation0.1272
MAPEMean absolute percentage error0.0396
SAESum of the absolute errors7.6293
As with simple exponential smoothing, in triple exponential smoothing models past Lixte Biotechnology observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Lixte Biotechnology Holdings observations.

Other Forecasting Options for Lixte Biotechnology

For every potential investor in Lixte, whether a beginner or expert, Lixte Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.

Lixte Biotechnology Related Equities

The following equities are related to Lixte Biotechnology within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Lixte Biotechnology against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
 Risk & Return  Correlation

Lixte Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on.

Lixte Biotechnology Risk Indicators

The analysis of Lixte Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lixte Biotechnology's investment and either accepting that risk or mitigating it.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Lixte Biotechnology

Coverage intensity for Lixte Biotechnology Holdings matters because narrative visibility can influence sentiment, participation, and volatility around the name. This is most useful when investors want to understand why a security is suddenly drawing more public discussion.

Lixte Biotechnology Short Properties

Reviewing short-oriented indicators for Lixte Biotechnology Holdings is useful because long and short participants often create very different signals for timing and volatility. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding2.2 M
Cash And Short Term InvestmentsM

Additional Tools for Lixte Stock Analysis

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash position to determine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data